PFE Stock Price, Chart, Stats & News

Pfizer Inc.
Save
PFE chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 70.33% |
Operating margin | 24.67% |
Pretax margin | 12.02% |
Net margin | 12.42% |
Effective tax rate | -3.54% |
ROA | 3.73% |
ROE | 8.67% |
D/E | 0.78x |
Interest coverage ratio | 5.78x |
PFE valuation
P/E | 19.15x |
P/S | 2.46x |
P/B | 1.78x |
P/CF | 13.12x |
P/FCF | 16.94x |
P/OCF | 13.12x |
PEG | -0.92x |
EV multiple | 5.21x |
About
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit.
Similar securities
Based on sector and market capitalization
Report issue










